• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Update in lung cancer and mesothelioma 2012.

作者信息

Powell Charles A, Halmos Balazs, Nana-Sinkam Serge P

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

Am J Respir Crit Care Med. 2013 Jul 15;188(2):157-66. doi: 10.1164/rccm.201304-0716UP.

DOI:10.1164/rccm.201304-0716UP
PMID:23855692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3778761/
Abstract
摘要

相似文献

1
Update in lung cancer and mesothelioma 2012.2012年肺癌与间皮瘤最新进展
Am J Respir Crit Care Med. 2013 Jul 15;188(2):157-66. doi: 10.1164/rccm.201304-0716UP.
2
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.IV期非小细胞肺癌的全身治疗：美国临床肿瘤学会临床实践指南更新摘要
J Oncol Pract. 2017 Dec;13(12):832-837. doi: 10.1200/JOP.2017.026716. Epub 2017 Aug 29.
3
Validating ROS1 rearrangements as a therapeutic target in non-small-cell lung cancer.验证ROS1重排在非小细胞肺癌中作为治疗靶点的作用。
J Clin Oncol. 2015 Mar 20;33(9):972-4. doi: 10.1200/JCO.2014.59.8334. Epub 2015 Feb 9.
4
Immune Checkpoint Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer: A Report of Two Cases.ROS1重排的非小细胞肺癌中的免疫检查点抑制剂：两例报告
J Thorac Oncol. 2019 Aug;14(8):e165-e167. doi: 10.1016/j.jtho.2019.03.008.
5
A case series of lengthy progression-free survival with pemetrexed-containing therapy in metastatic non--small-cell lung cancer patients harboring ROS1 gene rearrangements.一组在携带ROS1基因重排的转移性非小细胞肺癌患者中使用含培美曲塞治疗实现长期无进展生存的病例系列。
Clin Lung Cancer. 2013 Sep;14(5):592-5. doi: 10.1016/j.cllc.2013.04.008. Epub 2013 Jun 27.
6
Patients with ROS1 rearrangement-positive non-small-cell lung cancer benefit from pemetrexed-based chemotherapy.ROS1重排阳性的非小细胞肺癌患者可从培美曲塞化疗中获益。
Cancer Med. 2016 Oct;5(10):2688-2693. doi: 10.1002/cam4.809. Epub 2016 Aug 20.
7
ROS1-rearranged Non-Small Cell Lung Cancers With Concomitant Oncogenic Driver Alterations: About Some Rare Therapeutic Dilemmas.伴有致癌驱动基因改变的ROS1重排非小细胞肺癌：关于一些罕见的治疗困境
Clin Lung Cancer. 2018 Jan;19(1):e73-e74. doi: 10.1016/j.cllc.2017.08.005. Epub 2017 Sep 1.
8
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.KRAS突变与突变型而非野生型EGFR共存可预测人类肺癌对酪氨酸激酶抑制剂的反应。
Br J Cancer. 2014 Nov 25;111(11):2203-4. doi: 10.1038/bjc.2014.401. Epub 2014 Aug 12.
9
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.致癌驱动子亚型、程序性死亡受体-1 配体（PD-L1）评分和吸烟状态对驱动基因非小细胞肺癌患者 PD-1/PD-L1 抑制剂疗效的预测价值。
Cancer. 2019 Apr 1;125(7):1038-1049. doi: 10.1002/cncr.31871. Epub 2018 Dec 11.
10
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma.ROS1 重排对从不吸烟的肺腺癌患者临床结局的频率和影响。
Ann Oncol. 2013 Sep;24(9):2364-70. doi: 10.1093/annonc/mdt220. Epub 2013 Jun 19.

引用本文的文献

1
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts.近红外光免疫疗法（NIR-PIT）在消化道和呼吸道癌症中的内镜应用
Biomedicines. 2022 Apr 4;10(4):846. doi: 10.3390/biomedicines10040846.
2
circRNA LDLRAD3 Enhances the Malignant Behaviors of NSCLC Cells via the miR-20a-5p-SLC7A5 Axis Activating the mTORC1 Signaling Pathway.环状 RNA LDLRAD3 通过 miR-20a-5p-SLC7A5 轴激活 mTORC1 信号通路增强 NSCLC 细胞的恶性行为。
J Healthc Eng. 2022 Jan 6;2022:2373580. doi: 10.1155/2022/2373580. eCollection 2022.
3
[Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer].[血小板淋巴细胞比值作为非小细胞肺癌预后因素的Meta分析]
Zhongguo Fei Ai Za Zhi. 2019 May 20;22(5):289-298. doi: 10.3779/j.issn.1009-3419.2019.05.05.
4
Global Epidemiology of Lung Cancer.全球肺癌流行病学。
Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419.
5
Clinicopathologic characteristics of non-small cell lung cancer in patients with smoking-related chronic obstructive pulmonary disease.吸烟相关慢性阻塞性肺疾病患者非小细胞肺癌的临床病理特征
Gen Thorac Cardiovasc Surg. 2019 Feb;67(2):239-246. doi: 10.1007/s11748-018-1007-x. Epub 2018 Sep 5.
6
Inhibition of protein kinase CK2 sensitizes non-small cell lung cancer cells to cisplatin via upregulation of PML.抑制蛋白激酶 CK2 通过上调 PML 使非小细胞肺癌细胞对顺铂敏感。
Mol Cell Biochem. 2017 Dec;436(1-2):87-97. doi: 10.1007/s11010-017-3081-2. Epub 2017 Jul 25.
7
Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis.血小板与淋巴细胞比值在非小细胞肺癌中的预后意义：一项荟萃分析
Onco Targets Ther. 2016 Feb 22;9:869-76. doi: 10.2147/OTT.S96804. eCollection 2016.
8
Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.慢性阻塞性肺疾病对非小细胞肺癌切除术后复发的影响。
Int J Chron Obstruct Pulmon Dis. 2015 Dec 29;11:43-9. doi: 10.2147/COPD.S97411. eCollection 2016.
9
Clinical value of microRNA-23a upregulation in non-small cell lung cancer.非小细胞肺癌中微小RNA-23a上调的临床价值
Int J Clin Exp Med. 2015 Aug 15;8(8):13598-603. eCollection 2015.
10
Tumstatin 185-191 increases the sensitivity of non-small cell lung carcinoma cells to cisplatin by blocking proliferation, promoting apoptosis and inhibiting Akt activation.肿瘤抑素185 - 191通过阻断增殖、促进凋亡和抑制Akt激活来增加非小细胞肺癌细胞对顺铂的敏感性。
Am J Transl Res. 2015 Aug 15;7(8):1332-44. eCollection 2015.

本文引用的文献

1
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.随机 III 期试验：单药培美曲塞对比卡铂和培美曲塞用于晚期非小细胞肺癌且东部肿瘤协作组体能状态评分 2 分的患者。
J Clin Oncol. 2013 Aug 10;31(23):2849-53. doi: 10.1200/JCO.2012.48.1911. Epub 2013 Jun 17.
2
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.克唑替尼与化疗用于治疗晚期 ALK 阳性肺癌。
N Engl J Med. 2013 Jun 20;368(25):2385-94. doi: 10.1056/NEJMoa1214886. Epub 2013 Jun 1.
3
Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.执行摘要：《肺癌的诊断与管理》第3版：美国胸科医师学会循证临床实践指南
Chest. 2013 May;143(5 Suppl):7S-37S. doi: 10.1378/chest.12-2377.
4
Cancer statistics, 2013.癌症统计数据，2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
5
Biomarkers to help guide management of patients with pulmonary nodules.有助于指导肺结节患者管理的生物标志物。
Am J Respir Crit Care Med. 2013 Aug 15;188(4):461-5. doi: 10.1164/rccm.201210-1760OC.
6
Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.Ⅰ期肺腺癌中免疫微环境的临床影响：肿瘤白细胞介素-12 受体β2（IL-12Rβ2）、白细胞介素-7 受体（IL-7R）和基质 FoxP3/CD3 比值是复发的独立预测因子。
J Clin Oncol. 2013 Feb 1;31(4):490-8. doi: 10.1200/JCO.2012.45.2052. Epub 2012 Dec 26.
7
Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor β-induced epithelial-to-mesenchymal transition.非典型蛋白激酶 C 使 Par6 磷酸化，从而促进转化生长因子 β 诱导的上皮间质转化。
Mol Cell Biol. 2013 Mar;33(5):874-86. doi: 10.1128/MCB.00837-12. Epub 2012 Dec 17.
8
EMT and MET in metastasis: where are the cancer stem cells?上皮间质转化（EMT）和间质上皮转化（MET）在转移中的作用：癌症干细胞在哪里？
Cancer Cell. 2012 Dec 11;22(6):699-701. doi: 10.1016/j.ccr.2012.11.009.
9
Enriching the molecular definition of the airway "field of cancerization:" establishing new paradigms for the patient at risk for lung cancer.丰富气道“癌变领域”的分子定义：为肺癌高危患者建立新的范例。
Cancer Prev Res (Phila). 2013 Jan;6(1):4-7. doi: 10.1158/1940-6207.CAPR-12-0470. Epub 2012 Dec 11.
10
Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans.5p15.33、6p22.1-p21.31 和 15q25.1 区域的精细定位确定了非裔美国人中具有功能和组织学特异性的肺癌易感性位点。
Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):251-60. doi: 10.1158/1055-9965.EPI-12-1007-T. Epub 2012 Dec 5.